Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

View:
Post by Kingofstockst on Apr 19, 2020 9:46pm

I will

Never understand how some ppl here don't see anything wrong with this company, I'm invested in TBP man that company has NR all the time to update shareholders we have q&a with ceo always accessible they have 4 orphan drug designations with FDA, this team never updates us always lies stock price goes only 1 way common ppl can't be this blind... I'm invested in this but how can you not see the problem?????
Comment by Kingofstockst on Apr 19, 2020 10:23pm
I guess ppl would rather attack someone who brings up valid points instead of checking our crooked management...
Comment by BrendaNashh on Apr 19, 2020 10:40pm
This post has been removed in accordance with Community Policy
Comment by indaknownewfie on Apr 20, 2020 3:12pm
Hey King. I, like you am heavily in TBP and I love what they do for us as shareholders, but I will tell you this. TBP is the exception rather than the rule. They are probably the best example that the other biotechs should aspire to be. i;m not sure how long you have been investing, not intended to be a slight, but during my time, many biotechs simply do not do NR or engage until they have ...more  
Comment by Kingofstockst on Apr 20, 2020 3:18pm
It's fair and accurate what you're saying, would you have the 4 orphan drug designations with the fda? I mean the codes or proper names so I can search them?
Comment by Belgiumboy on Apr 20, 2020 3:56pm
Indaknow, thanks for this beautiful post. Can I ask you a question please. I would like to hear your reaction on the idea Kalytera may be working on conditional FDA approval at this moment behind the scenes because of outstanding phase 2 results. We didn't hear anything about the research since the breakthroug in august, which may suggest something is going on.... What do you think about that?
Comment by indaknownewfie on Apr 20, 2020 4:33pm
Well my reaction would only be my opinion. Could Kalytera be working on a conditional FDA approval behind the scenes? Absolutely because the results were so stellar. Do I think something is brewing behind the scenes?  I've long held the belief that there is more happening behind the scenes. Perhaps that is conjecture on my part. I wouldn't want anyone to make an investment solely on ...more  
Comment by Belgiumboy on Apr 21, 2020 5:44am
Thanks for your reaction Indaknow